1. Home
  2. EMBC vs BCX Comparison

EMBC vs BCX Comparison

Compare EMBC & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • BCX
  • Stock Information
  • Founded
  • EMBC 1924
  • BCX 2011
  • Country
  • EMBC United States
  • BCX United States
  • Employees
  • EMBC N/A
  • BCX N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • BCX Finance/Investors Services
  • Sector
  • EMBC Health Care
  • BCX Finance
  • Exchange
  • EMBC Nasdaq
  • BCX Nasdaq
  • Market Cap
  • EMBC 838.7M
  • BCX 750.7M
  • IPO Year
  • EMBC N/A
  • BCX N/A
  • Fundamental
  • Price
  • EMBC $13.83
  • BCX $10.28
  • Analyst Decision
  • EMBC Buy
  • BCX
  • Analyst Count
  • EMBC 2
  • BCX 0
  • Target Price
  • EMBC $18.50
  • BCX N/A
  • AVG Volume (30 Days)
  • EMBC 514.0K
  • BCX 370.6K
  • Earning Date
  • EMBC 11-25-2025
  • BCX 01-01-0001
  • Dividend Yield
  • EMBC 4.32%
  • BCX 6.99%
  • EPS Growth
  • EMBC 18.26
  • BCX N/A
  • EPS
  • EMBC 1.42
  • BCX N/A
  • Revenue
  • EMBC $1,102,500,000.00
  • BCX N/A
  • Revenue This Year
  • EMBC N/A
  • BCX N/A
  • Revenue Next Year
  • EMBC N/A
  • BCX N/A
  • P/E Ratio
  • EMBC $9.77
  • BCX N/A
  • Revenue Growth
  • EMBC N/A
  • BCX N/A
  • 52 Week Low
  • EMBC $9.20
  • BCX $8.25
  • 52 Week High
  • EMBC $21.48
  • BCX $9.90
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 44.40
  • BCX 63.71
  • Support Level
  • EMBC $13.78
  • BCX $10.26
  • Resistance Level
  • EMBC $14.78
  • BCX $10.40
  • Average True Range (ATR)
  • EMBC 0.53
  • BCX 0.12
  • MACD
  • EMBC -0.14
  • BCX 0.00
  • Stochastic Oscillator
  • EMBC 14.97
  • BCX 61.52

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About BCX BlackRock Resources of Beneficial Interest

BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.

Share on Social Networks: